Can application of serine protease inhibitors TPCK and TLCK provide evidence for possible involvement of serine protease Omi/HtrA2 in imatinib mesylate-induced cell death of BCR-ABL-positive human leukemia cell? [6]

Leukemia

Volumn 19, Issue 6, 2005, Pages 1085-1087

  Mlejnek, P ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CASPASE 3; IMATINIB; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE OMI; TOSYLLYSYL CHLOROMETHYL KETONE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; MITOCHONDRIAL PROTEIN; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PYRIMIDINE DERIVATIVE; SERINE PROTEINASE;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION (PARAMETERS); DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; LETTER; LEUKEMIA CELL LINE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; CELL CULTURE; LEUKEMIA; METABOLISM;

HUMANS; LEUKEMIA; MITOCHONDRIAL PROTEINS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; TOSYLLYSINE CHLOROMETHYL KETONE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; TUMOR CELLS, CULTURED;

EID: 20844442967     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403701     Document Type: Letter

References (8)

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
2. Sarin A, Wu ML, Henkart PA. Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med 1996; 184: 2445-2459.
3. Hirsch T, Marchetti P, Susin SA, Dallaporta B, Zamzami N, Marzo I et al. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997; 15: 1573-1581.
4. Van Grup M, Festjens N, van Loo G, Saelens X, Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 2003; 304: 487-497.
5. Okada M, Adachi S, Imai T, Watanabe K, Toyokuni S, Ueno M et al. A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 2004; 103: 2299-2307.
6. Lu Q, Mellgren RL. Calpain inhibitors and serine protease inhibitors can produce apoptosisin HL-60 cells. Arch Biochem Biophys 1996; 334: 175-181.
7. Otto HH, Schirmeister T. Cysteine proteases and their inhibitors. Chem Rev 1997; 97: 133-171.
8. Jacquel A, Herrant M, Legros L, Belhacene N, Luciano F, Pages G et al. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl positive K562 cell line and its differentiation towards the erythroid lineage. FASEB J 2003; 17: 2160-2172.